BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
Brainsway Ltd.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 20, 2026
$11.99+0.55 (+4.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 239.8
- Dividend yield
- –
Share price
+$3.99 (+49.88%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Brainsway Ltd. grew revenue 29.0% to $41.02M over fiscal 2024.
Revenue
$41.02M
+29.0% vs. a year earlier
Operating income
$1.39M
FY2024
EPS, diluted
$0.05
FY2024
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Jun 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- 239.8
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $41.02M
- EPS, diluted
- $0.05
Nine years at a glance
Fiscal years 2016 to 2024, USD
Revenue
$41.02M+29.0% YoY
Gross profit
$30.58M+30.3% YoY
Operating income
$1.39M
EPS, diluted
$0.05
Free cash flow
–
Reported period